Robert S. Kunkel, MD

Robert S. Kunkel, MD
Consultant, Cleveland Clinic Headache Center, Cleveland Clinic; past president, American Headache Society; past president, National Headache Foundation

Address: Robert S, Kunkel, MD, Headache Center, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

Robert S. Kunkel, MD
Consultant, Cleveland Clinic Headache Center, Cleveland Clinic; past president, American Headache Society; past president, National Headache Foundation

Address: Robert S, Kunkel, MD, Headache Center, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

Robert S. Kunkel, MD
Consultant, Cleveland Clinic Headache Center, Cleveland Clinic; past president, American Headache Society; past president, National Headache Foundation

Address: Robert S, Kunkel, MD, Headache Center, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

Robert S. Kunkel, MD
Consultant, Headache Center, Department of Neurology, The Cleveland Clinic Foundation

Address: Robert S. Kunkel, MD, FACP, Headache Center, Department of Neurology, T33, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Robert S. Kunkel, MD
Consultant, Headache Center, Department of Neurology, The Cleveland Clinic Foundation

Address: Robert S. Kunkel, MD, FACP, Headache Center, Department of Neurology, T33, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Robert S. Kunkel, MD
Consultant, Headache Center, Department of Neurology, The Cleveland Clinic Foundation

Address: Robert S. Kunkel, MD, FACP, Headache Center, Department of Neurology, T33, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.